CABS1
gene geneOn this page
Also known as NYD-SP26FLJ32897CLPH
Summary
CABS1 (calcium binding protein, spermatid associated 1, HGNC:30710) is a protein-coding gene on chromosome 4q13.3, encoding Calcium-binding and spermatid-specific protein 1 (Q96KC9). Calcium-binding protein.
Predicted to enable calcium ion binding activity. Predicted to be involved in flagellated sperm motility and spermatogenesis. Predicted to be located in acrosomal vesicle and sperm principal piece. Predicted to be active in mitochondrial inner membrane and motile cilium.
Source: NCBI Gene 85438 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_033122
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30710 |
| Approved symbol | CABS1 |
| Name | calcium binding protein, spermatid associated 1 |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NYD-SP26, FLJ32897, CLPH |
| Ensembl gene | ENSG00000145309 |
| Ensembl biotype | protein_coding |
| OMIM | 618600 |
| Entrez | 85438 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000273936
RefSeq mRNA: 1 — MANE Select: NM_033122
NM_033122
CCDS: CCDS3539
Canonical transcript exons
ENST00000273936 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000969875 | 70334981 | 70336346 |
| ENSE00000969876 | 70336966 | 70337116 |
Expression profiles
Bgee: expression breadth broad, 34 present calls, max score 99.37.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2080 / max 232.0322, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47914 | 0.1853 | 4 |
| 47913 | 0.0226 | 3 |
Top tissues by expression
216 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.37 | gold quality |
| left testis | UBERON:0004533 | 95.77 | gold quality |
| right testis | UBERON:0004534 | 94.64 | gold quality |
| testis | UBERON:0000473 | 92.66 | gold quality |
| adult organism | UBERON:0007023 | 86.02 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.03 | gold quality |
| buccal mucosa cell | CL:0002336 | 61.63 | silver quality |
| minor salivary gland | UBERON:0001830 | 59.08 | gold quality |
| mouth mucosa | UBERON:0003729 | 56.63 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 55.75 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| cauda epididymis | UBERON:0004360 | 53.38 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 52.84 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.26 | gold quality |
| deltoid | UBERON:0001476 | 46.22 | gold quality |
| tibialis anterior | UBERON:0001385 | 46.01 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.40 | gold quality |
| ileal mucosa | UBERON:0000331 | 45.11 | silver quality |
| pancreatic ductal cell | CL:0002079 | 45.06 | silver quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| muscle tissue | UBERON:0002385 | 42.10 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 41.44 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.79 |
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
32 targeting CABS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-3606-3P | 99.11 | 69.84 | 3254 |
| HSA-MIR-4699-5P | 98.99 | 67.50 | 1210 |
| HSA-MIR-12135 | 98.99 | 70.26 | 1814 |
| HSA-MIR-520G-3P | 98.91 | 67.38 | 1914 |
| HSA-MIR-520H | 98.91 | 67.38 | 1914 |
| HSA-MIR-4709-3P | 98.88 | 68.04 | 1594 |
| HSA-MIR-6889-3P | 98.84 | 67.35 | 1198 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-6529-3P | 98.68 | 66.76 | 1020 |
| HSA-MIR-3689A-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689B-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689E | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689F | 98.35 | 70.08 | 1052 |
| HSA-MIR-660-5P | 98.16 | 68.27 | 680 |
| HSA-MIR-4509 | 96.19 | 65.80 | 900 |
Literature-anchored findings (GeneRIF, showing 2)
- Human CABS1 has a peptide motif homologous to the anti-inflammatory peptide sequence of rat SMR1. (PMID:25632019)
- CABS1 is readily detected in human saliva and is associated with psychological and physiological indicators of stress. (PMID:28381457)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cabs1 | ENSMUSG00000007907 |
| rattus_norvegicus | Cabs1 | ENSRNOG00000001950 |
Protein
Protein identifiers
Calcium-binding and spermatid-specific protein 1 — Q96KC9 (reviewed: Q96KC9)
Alternative names: Testis development protein NYD-SP26
All UniProt accessions (1): Q96KC9
UniProt curated annotations — full annotation on UniProt →
Function. Calcium-binding protein. Essential for maintaining the structural integrity of the sperm flagella.
Subcellular location. Cytoplasm. Mitochondrion inner membrane. Cell projection. Cilium. Flagellum. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
RefSeq proteins (1): NP_149113* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026118 | Ca-bd_spermatid | Family |
Pfam: PF15367
UniProt features (11 total): modified residue 4, sequence variant 3, region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KC9-F1 | 40.00 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 273, 287, 319, 376
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_MALE_GAMETE_GENERATION, chr4q13, MODULE_205, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOCC_MITOCHONDRIAL_ENVELOPE, ATTCTTT_MIR186, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_SECRETORY_VESICLE, GOCC_MOTILE_CILIUM, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_SPERM_PRINCIPAL_PIECE, GOCC_ACROSOMAL_VESICLE, GOCC_CILIUM
GO Biological Process (2): spermatogenesis (GO:0007283), flagellated sperm motility (GO:0030317)
GO Molecular Function (1): calcium ion binding (GO:0005509)
GO Cellular Component (10): acrosomal vesicle (GO:0001669), mitochondrial inner membrane (GO:0005743), motile cilium (GO:0031514), sperm principal piece (GO:0097228), cytoplasm (GO:0005737), mitochondrion (GO:0005739), cilium (GO:0005929), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cytoplasm | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| metal ion binding | 1 |
| secretory granule | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cilium | 1 |
| sperm flagellum | 1 |
| intracellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
422 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CABS1 | SHCBP1L | Q9BZQ2 | 644 |
| CABS1 | LRCOL1 | A6NCL2 | 581 |
| CABS1 | C20orf173 | Q96LM9 | 581 |
| CABS1 | PRR27 | Q6MZM9 | 543 |
| CABS1 | TMCO5A | Q8N6Q1 | 536 |
| CABS1 | SPMIP4 | Q8N865 | 531 |
| CABS1 | SPATA31G1 | Q5VYM1 | 507 |
| CABS1 | TTC21A | Q8NDW8 | 502 |
| CABS1 | ROPN1L | Q96C74 | 487 |
| CABS1 | ROPN1 | Q9HAT0 | 484 |
| CABS1 | FAM229B | Q4G0N7 | 478 |
| CABS1 | CCDC187 | A0A096LP49 | 476 |
| CABS1 | SMR3A | Q99954 | 470 |
| CABS1 | TMCO2 | Q7Z6W1 | 470 |
| CABS1 | CAPZA3 | Q96KX2 | 460 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CABS1 | TRAPPC10 | psi-mi:“MI:0914”(association) | 0.530 |
| CABS1 | psi-mi:“MI:0914”(association) | 0.350 | |
| CABS1 | ALOX12B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (31): TRAPPC4 (Affinity Capture-MS), TRAPPC10 (Affinity Capture-MS), C7orf43 (Affinity Capture-MS), TRAPPC9 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), TRAPPC2L (Affinity Capture-MS), TRAPPC3 (Affinity Capture-MS), TRAPPC1 (Affinity Capture-MS), C7orf43 (Affinity Capture-MS), TRAPPC10 (Affinity Capture-MS), TRAPPC9 (Affinity Capture-MS), TRAPPC4 (Affinity Capture-MS), TRAPPC2L (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS)
ESM2 similar proteins: A0JPP4, B7ZCC9, B9EKR1, E9Q7X6, J3KML8, O00592, O57604, P13611, P23471, P30005, P34910, P52549, P70628, Q01036, Q06093, Q1XI86, Q28858, Q2TA21, Q2TBJ9, Q3MIW9, Q3TNW5, Q3TYV2, Q5XI99, Q62059, Q62656, Q62781, Q68FD9, Q69558, Q6MG22, Q6R8J2, Q7TST5, Q80XH2, Q86TY3, Q8BT18, Q8BUE7, Q8C633, Q8IZF6, Q8N3K9, Q8VD58, Q8WXI7
Diamond homologs: Q2TBJ9, Q68FX6, Q8C633, Q95JW6, Q96KC9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
173 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:70336211:A:G | donor_gain | 0.9900 |
| 4:70336156:G:GT | donor_gain | 0.9600 |
| 4:70336201:G:GT | donor_gain | 0.9600 |
| 4:70336210:GA:G | donor_gain | 0.9000 |
| 4:70336211:A:AG | donor_gain | 0.9000 |
| 4:70336241:G:T | donor_gain | 0.8400 |
| 4:70336240:GGA:G | donor_gain | 0.7900 |
| 4:70336042:G:GT | donor_gain | 0.6500 |
| 4:70335883:G:T | donor_gain | 0.6200 |
| 4:70335999:A:G | donor_gain | 0.6200 |
| 4:70335919:G:GT | donor_gain | 0.6100 |
| 4:70336157:A:T | donor_gain | 0.6000 |
| 4:70336198:A:T | donor_gain | 0.5900 |
| 4:70336390:TC:T | donor_gain | 0.5900 |
| 4:70336431:GT:G | donor_gain | 0.5900 |
| 4:70335883:G:GT | donor_gain | 0.5600 |
| 4:70336180:GA:G | donor_gain | 0.5600 |
| 4:70335955:G:GT | donor_gain | 0.5500 |
| 4:70336250:T:TA | donor_gain | 0.5400 |
| 4:70336251:A:AA | donor_gain | 0.5400 |
| 4:70335766:GACC:G | donor_gain | 0.5300 |
| 4:70335769:C:G | donor_gain | 0.5300 |
| 4:70336121:G:GT | donor_gain | 0.5200 |
| 4:70336215:G:GG | donor_gain | 0.5000 |
| 4:70336248:T:G | donor_gain | 0.5000 |
| 4:70336214:A:AG | donor_gain | 0.4900 |
| 4:70336981:T:G | acceptor_gain | 0.4800 |
| 4:70336181:A:G | donor_gain | 0.4700 |
| 4:70336216:T:G | donor_gain | 0.4500 |
| 4:70336971:A:C | acceptor_gain | 0.4500 |
AlphaMissense
2601 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:70335841:T:C | F268L | 0.976 |
| 4:70335843:T:A | F268L | 0.976 |
| 4:70335843:T:G | F268L | 0.976 |
| 4:70336006:T:C | F323L | 0.959 |
| 4:70336008:C:A | F323L | 0.959 |
| 4:70336008:C:G | F323L | 0.959 |
| 4:70335986:C:A | A316D | 0.929 |
| 4:70336186:T:C | F383L | 0.919 |
| 4:70336188:T:A | F383L | 0.919 |
| 4:70336188:T:G | F383L | 0.919 |
| 4:70335842:T:C | F268S | 0.918 |
| 4:70335985:G:C | A316P | 0.918 |
| 4:70335994:T:C | S319P | 0.914 |
| 4:70335434:T:C | L132S | 0.899 |
| 4:70335217:T:C | F60L | 0.892 |
| 4:70335219:T:A | F60L | 0.892 |
| 4:70335219:T:G | F60L | 0.892 |
| 4:70335842:T:G | F268C | 0.891 |
| 4:70335980:T:C | L314P | 0.886 |
| 4:70336007:T:C | F323S | 0.876 |
| 4:70335428:T:A | V130D | 0.874 |
| 4:70335839:T:A | V267E | 0.874 |
| 4:70335848:T:C | L270P | 0.860 |
| 4:70335980:T:A | L314H | 0.847 |
| 4:70335442:T:C | F135L | 0.845 |
| 4:70335444:T:A | F135L | 0.845 |
| 4:70335444:T:G | F135L | 0.845 |
| 4:70336000:T:G | Y321D | 0.834 |
| 4:70335829:T:C | F264L | 0.828 |
| 4:70335831:T:A | F264L | 0.828 |
dbSNP variants (sampled 300 via entrez): RS1000533156 (4:70336416 GA>G,GAA,GAAA), RS1001089388 (4:70335870 C>A,T), RS1003859529 (4:70336286 A>T), RS1005502453 (4:70337544 A>T), RS1005879607 (4:70336334 G>T), RS1006326401 (4:70336578 A>G), RS1007129101 (4:70337264 A>G), RS1008833357 (4:70336224 T>C), RS1009144258 (4:70334588 A>G), RS1009790014 (4:70335076 C>A,T), RS1010096113 (4:70337058 A>G), RS1013470893 (4:70336651 A>G), RS1013661408 (4:70336901 T>G), RS1014133307 (4:70336359 C>T), RS1015419282 (4:70335674 T>C)
Disease associations
OMIM: gene MIM:618600 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 2 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment, decreases expression | 1 |
| Vorinostat | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.